254 related articles for article (PubMed ID: 5416772)
1. Standardization of laboratory tests for controlling anticoagulent therapy.
Zucker S; Cathey MH; Sox PJ; Hall EC
Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
[No Abstract] [Full Text] [Related]
2. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
3. Dilution curve studies in prothrombin complex factors deficiencies and abnormalities.
Girolami A; Brunetti A; DeMarco L; Fioretti D
Blut; 1974 Aug; 29(2):134-43. PubMed ID: 4851393
[No Abstract] [Full Text] [Related]
4. Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
Denson KW
Thromb Diath Haemorrh Suppl; 1967; 26():437-40. PubMed ID: 6064874
[No Abstract] [Full Text] [Related]
5. Prothrombin level in coumarin-treated patients. A peculiar effect observed in a one-stage system using certain substrates.
Girolami A; Bareggi G; Cella G; Patrassi G
Am J Clin Pathol; 1974 May; 61(5):654-61. PubMed ID: 4857077
[No Abstract] [Full Text] [Related]
6. Criteria for an acceptable thromboplastin preparation.
Owren PA
Thromb Diath Haemorrh; 1975 Apr; 33(2):165-71. PubMed ID: 49085
[No Abstract] [Full Text] [Related]
7. Prothrombin time standardization: Proposal of the standards committee, College of American Pathologists.
Miale JB; LaFond DJ
Thromb Diath Haemorrh Suppl; 1968; 35():107-1. PubMed ID: 5761058
[No Abstract] [Full Text] [Related]
8. Inhibitor of human blood coagulation elicited by thrombin.
Marciniak E
J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
[No Abstract] [Full Text] [Related]
9. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
DOKU HC; TAYLOR RG; SISE HS; BECKER R
J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
[No Abstract] [Full Text] [Related]
10. Preparation of canine factor VII deficient substrate plasma.
Gaston LW; Spivack AR
J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
[No Abstract] [Full Text] [Related]
11. Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
Biggs R; Denson KW
Thromb Diath Haemorrh Suppl; 1967; 26():445-50. PubMed ID: 6064876
[No Abstract] [Full Text] [Related]
12. Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: availability and use of thromboplastin reference preparations.
Biggs R; Bangham DR
Br Med J; 1971 Aug; 3(5772):470-1. PubMed ID: 5105905
[No Abstract] [Full Text] [Related]
13. [Factors V, VII, and X--interpretation of test results].
Fukutake K; Ukita M
Nihon Rinsho; 1973; 31():1734-9. PubMed ID: 4582277
[No Abstract] [Full Text] [Related]
14. THE ACTIVATION OF FACTOR X BY EXTRACTS OF RABBIT BRAIN.
NEMERSON Y; SPAET TH
Blood; 1964 May; 23():657-68. PubMed ID: 14142504
[No Abstract] [Full Text] [Related]
15. Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.
Levanon M; Rimon S; Shani M; Ramot B; Goldberg E
Br J Haematol; 1972 Dec; 23(6):669-77. PubMed ID: 4675008
[No Abstract] [Full Text] [Related]
16. Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations.
Loeliger EA; Meuwisse-Braun JB; Muis H; Buitendijk FJ; Veltkamp JJ; Hemker HC
Thromb Diath Haemorrh; 1970 Jun; 23(3):569-84. PubMed ID: 5432194
[No Abstract] [Full Text] [Related]
17. Standardisation of the one-stage prothrombin time test for the control of anticoagulant therapy: the availability and use of thromboplastin reference preparations.
Nord Med; 1971 Oct; 86(40):1154-5. PubMed ID: 5167204
[No Abstract] [Full Text] [Related]
18. Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: the availability and use of thromboplastin reference preparations.
Biggs R; Bangham DR
Am J Clin Pathol; 1972 Jan; 57(1):117-8. PubMed ID: 5008887
[No Abstract] [Full Text] [Related]
19. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
Pineo GF; Regoeczi E; Hatton MW; Brain MC
J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
[No Abstract] [Full Text] [Related]
20. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
Kolde HJ
Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
[No Abstract] [Full Text] [Related]
[Next] [New Search]
